CHECKMATE PHARMACEUTICALS IN's ticker is CMPI and the CUSIP is 162818108. A total of 1 filers reported holding CHECKMATE PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,000 | -75.0% | 183 | -83.4% | 0.00% | – |
| Q4 2021 | $4,000 | +300.0% | 1,105 | +503.8% | 0.00% | – |
| Q3 2021 | $1,000 | -95.0% | 183 | -94.4% | 0.00% | – |
| Q2 2021 | $20,000 | -44.4% | 3,296 | +11.5% | 0.00% | – |
| Q1 2021 | $36,000 | -16.3% | 2,956 | +0.2% | 0.00% | – |
| Q4 2020 | $43,000 | +514.3% | 2,950 | +355.2% | 0.00% | – |
| Q3 2020 | $7,000 | – | 648 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 0 | $0 | 0.00% |